Research advances in diagnosis and treatment of cardiomyopathy associated with immune checkpoint inhibitors
Immune checkpoint inhibitors(ICIs)have shown remarkable success in increasing tumor patients'survival rates,but the increasing immune-related adverse cardiovascular events seriously affect the treatment and prognosis of these patients.This review summarizes the latest research advances in the pathogenesis,clinical manifestations,diagnosis and treatment of ICIs-related cardiomyopathy in order to provide references for both cardiologists and oncologists in clinical practice.
万方数据
维普
